In mouse mammary gland, progestins substantially stimulate RANKL expression in PR-positive cells, leading to paracrine activation of PR-negative mammary stem cells and progression of progestin-driven mammary cancer [6–8]. The gene discussed is PGR; the disease is breast cancer.